Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Rat C Peptide ELISA Kit (AC3828)
Cat.#: ASET-2417
Specifications
Description Rat C Peptide ELISA Kit allows for the in vitro quantitative determination of rat C Peptide concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Rat Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 46.875 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 78.125-5000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2366 Human Wnt3a ELISA Kit (AC3777) Quantitative inquiry ASET-1333 Mouse Estrogen Receptor alpha ELISA Kit (AC2744) Quantitative inquiry ASET-1471 Mouse GSK3 beta ELISA Kit (AC2882) Quantitative inquiry ASET-1903 Human DUOX1 ELISA Kit (AC3314) Quantitative inquiry ASET-1799 Human CaMKII alpha ELISA Kit (AC3210) Quantitative inquiry ASET-2514 Human ABCA7 ELISA Kit (AC3925) Quantitative inquiry ASET-1174 Human NF-kB p65 ELISA Kit (AC2585) Quantitative inquiry ASET-1207 Human ALDH1A1 ELISA Kit (AC2618) Quantitative inquiry ASET-2207 Human CHRNA2 ELISA Kit (AC3618) Quantitative inquiry ASET-1684 Human BMAL1 ELISA Kit (AC3095) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket